Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Vernot

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 1, 1985
Intravitreal toxicity of hydroxyacyclovir (BW-B759U), a new antiviral agentJ Pulido, G A Peyman, T Lesar, et al.
Ophthalmic Surgery|February 1, 1986
Toxicity of intravitreal interferonS Vegh, G A Peyman, J Vernot, et al.
Ophthalmic Surgery|January 1, 1987
Toxicity of intravitreally administered alpha-interferonS K Dharma, G A Peyman, J Vernot, et al.
Investigative Ophthalmology & Visual Science|October 1, 1986
Vitreous glucose in bacterial and sterile endophthalmitisB R Garretson, T A Deutsch, J T Ernest, et al.
International Ophthalmology|November 1, 1985
Effects of selected repeated intravitreal chemotherapeutic agentsJ Vernot, G A Peyman, R Gailitis, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Archives of Ophthalmology (Chicago, Ill. : 1960)|June 1, 1985
Intravitreal toxicity of hydroxyacyclovir (BW-B759U), a new antiviral agentJ Pulido, G A Peyman, T Lesar, et al.
Ophthalmic Surgery|February 1, 1986
Toxicity of intravitreal interferonS Vegh, G A Peyman, J Vernot, et al.
Ophthalmic Surgery|January 1, 1987
Toxicity of intravitreally administered alpha-interferonS K Dharma, G A Peyman, J Vernot, et al.
Investigative Ophthalmology & Visual Science|October 1, 1986
Vitreous glucose in bacterial and sterile endophthalmitisB R Garretson, T A Deutsch, J T Ernest, et al.
International Ophthalmology|November 1, 1985
Effects of selected repeated intravitreal chemotherapeutic agentsJ Vernot, G A Peyman, R Gailitis, et al.
Pageof 1